Correlation between symmetry breaker position and the preferences of conformationally constrained homopeptides: a molecular dynamics investigation.
Juan Torras, David Zanuy, Marco Crisma, Claudio Toniolo, Oscar Betran, Carlos Alemán
文献索引:Biopolymers 90(5) , 695-706, (2008)
全文:HTML全文
摘要
The conformational tendencies of C(alpha,alpha)-diethylglycine (Deg)-based peptides have been studied in solution using all atom molecular dynamics simulations. Specifically, the conformational effects of breaking the symmetry of the host Tfa-(Deg)(5)-OtBu (Tfa, trifluoroacetyl; OtBu, tert-butoxy) pentapeptide with punctual replacements at different sequence positions of one Deg residue by its corresponding guest chiral analogue, L-alpha-aminobutyric acid (L-Abu), have been examined by simulating the following peptides: Tfa-(Deg)(5)-OtBu, Tfa-(Deg)(2)-L-Abu-(Deg)(2)-OtBu, Tfa-(Deg)(3)-L-Abu-Deg-OtBu, and Tfa-(Deg)(4)-L-Abu-OtBu. Simulations show that only the Deg homopeptide is able to stabilize a 2.0(5) helix, even though a kinked arrangement with all the Deg residues adopting a fully-extended conformation was found to be stable when the L-Abu residue is introduced in the middle of the sequence. On the other hand, when the L-Abu residue is closer to the C-end of the sequence, the peptide chain prefers a partially folded 3(10)-helix. Additional simulations on Tfa-(Deg)(3)-L-Abu-(Deg)(3)-OtBu highlighted that, when the size of the Deg segments increases, their tendency to adopt a 2.0(5) helix predominates over the preferred folded conformation of L-Abu. The overall picture extracted after more than 300 ns of molecular dynamics simulation is that breaking the alpha-carbon symmetry of achiral C(alpha)-tetrasubstituted amino acids is a promising strategy to build up polypeptides with modulated conformational tendencies.(c) 2008 Wiley Periodicals, Inc.
相关化合物
相关文献:
2005-11-01
[Clin. Chim. Acta 361(1-2) , 150-8, (2005)]
2001-07-01
[J. Clin. Gastroenterol. 33(1) , 36-40, (2001)]
2011-04-01
[Anal. Chem. 83(7) , 2705-11, (2011)]
2004-02-01
[Clin. Chem. Lab Med. 42(2) , 186-91, (2004)]
2000-01-01
[Blood Purif. 18(2) , 97-102, (2000)]